Decitabine
2025-16661
Phase 1 small_molecule active
Quick answer
Decitabine for Acute Myeloid Leukemia is a Phase 1 program (small_molecule) at Foghorn Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Foghorn Therapeutics
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active